Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Gianna Di Giovamberardino"'
Autor:
Francesco Bellomo, Ester De Leo, Anna Taranta, Laura Giaquinto, Gianna Di Giovamberardino, Sandro Montefusco, Laura Rita Rega, Anna Pastore, Diego Luis Medina, Diego Di Bernardo, Maria Antonietta De Matteis, Francesco Emma
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 23, p 12829 (2021)
Diagnosis and cure for rare diseases represent a great challenge for the scientific community who often comes up against the complexity and heterogeneity of clinical picture associated to a high cost and time-consuming drug development processes. Her
Externí odkaz:
https://doaj.org/article/98bad27755484d9aa5347e34f31a47fd
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-3 (2018)
Externí odkaz:
https://doaj.org/article/6c8ff5d80af848d88febf76f0bf5f167
Autor:
Anna Pastore, Anna Alisi, Gianna di Giovamberardino, Annalisa Crudele, Sara Ceccarelli, Nadia Panera, Carlo Dionisi-Vici, Valerio Nobili
Publikováno v:
International Journal of Molecular Sciences, Vol 15, Iss 11, Pp 21202-21214 (2014)
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of metabolic abnormalities ranging from simple triglyceride accumulation in the hepatocytes to hepatic steatosis with inflammation, ballooning and fibrosis. It has been demonstrated that the pat
Externí odkaz:
https://doaj.org/article/862a7446584e48da8aa8e9cd4a0758af
Autor:
Francesco De Peppo, Andrea Onetti Muda, Antonella Mosca, Sonia Battaglia, Nadia Panera, Gianna Di Giovamberardino, Romina Caccamo, Rita De Vito, D. Camanni, Anna Pastore, Paola Francalanci, Cristiano De Stefanis, Arianna Alterio, Annalisa Crudele, Anna Alisi
Publikováno v:
Obesity Surgery. 32:82-89
Paediatric obesity is a well-known risk factor for metabolic-associated fatty liver disease (MAFLD). The aim of this study was to evaluate the effects of laparoscopic sleeve gastrectomy (LSG) on the levels of total homocysteine (tHcy) and total gluta
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-3 (2018)
Autor:
Nathalie Nevo, Anna Pastore, Giulia Battafarano, Ottavia Porzio, Matteo D'Agostini, Gianna Di Giovamberardino, Andrea Del Fattore, Anna Taranta, Michela Rossi, Laura Rita Rega, Francesco Emma
Publikováno v:
The American journal of pathology. 189(5)
Cystinosis is a rare lysosomal storage disorder caused by loss-of-function mutations of the CTNS gene, encoding cystinosin, a symporter that mediates cystine efflux from lysosomes. Approximately 95% of patients with cystinosis display renal Fanconi s
Autor:
Margherita Ruoppolo, Diego Martinelli, Ferdinando Ceravolo, Carlo Dionisi-Vici, Anna Pastore, Laura Ingenito, Gianna Di Giovamberardino, Marianna Caterino, Maria Grazia Strozziero, Emanuela Scolamiero, Sara Boenzi, Esther Imperlini
Publikováno v:
Journal of Inherited Metabolic Disease. 38:969-979
Methylmalonic acidemia with homocystinuria, cobalamin deficiency type C (cblC) (MMACHC) is the most common inborn error of cobalamin metabolism. Despite a multidrug treatment, the long-term follow-up of early-onset patients is often unsatisfactory, w
Autor:
Annalisa Crudele, Gianna Di Giovamberardino, Anna Pastore, Carlo Dionisi-Vici, Valerio Nobili, Nadia Panera, Anna Alisi, Sara Ceccarelli
Publikováno v:
International Journal of Molecular Sciences, Vol 15, Iss 11, Pp 21202-21214 (2014)
International Journal of Molecular Sciences
Volume 15
Issue 11
Pages 21202-21214
International Journal of Molecular Sciences
Volume 15
Issue 11
Pages 21202-21214
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of metabolic abnormalities ranging from simple triglyceride accumulation in the hepatocytes to hepatic steatosis with inflammation, ballooning and fibrosis. It has been demonstrated that the pat
Autor:
Carlo Dionisi-Vici, Diego Martinelli, Sara Petrillo, Fiorella Piemonte, Giulia Tozzi, Enrico Bertini, Gianna Di Giovamberardino, Anna Pastore, Sara Boenzi
Publikováno v:
Journal of Inherited Metabolic Disease. 37:125-129
Methylmalonic aciduria with homocystinuria, cblC defect, is the most frequent disorder of vitamin B12 metabolism. CblC patients are commonly treated with a multidrug therapy to reduce metabolite accumulation and to increase deficient substrates. Howe
Autor:
Carlo Dionisi-Vici, Gianna Di Giovamberardino, Sara Boenzi, Sara Petrillo, Enrico Bertini, Anna Pastore, Fiorella Piemonte
Publikováno v:
Biomarkers. 17:764-766
Coenzyme Q(10) (CoQ(10)) is present in humans in both the reduced (ubiquinol, CoQ(10)H(2)) and oxidized (ubiquinone, CoQ(10)) forms. CoQ(10) is an essential cofactor in mitochondrial oxidative phosphorylation, and is necessary for ATP production. Tot